Hypoxia tumor-associated macrophages facilitate hepatocellular carcinoma metastasis via uPA-uPAR pathway.
Tumor oxygen starvation reprograms immune cells to fuel liver cancer spread, suggesting combination therapy targeting both hypoxia and immune signaling.
This Journal of Translational Medicine study demonstrates that hypoxic conditions in HCC reprogram tumor-associated macrophages to facilitate cancer cell invasion and metastasis through the urokinase plasminogen activator (uPA)/uPAR pathway. Targeting the hypoxia-TAM-uPAR axis could potentially enhance immunotherapy efficacy in a subset of HCC patients with highly metastatic disease.
What the study was
- Study design
- translational_mechanistic
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- J Transl Med
Why it surfaced
Captured via sentinel scan; HCC metastasis mechanism with potential immunotherapy combination implications; J Transl Med is moderate-impact; relevant to precision oncology and novel therapeutics watchlist topics; scored STANDARD as sentinel pick due to limited clinical evidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.